While at Novartis he helped launch key products within the Maalox® and Lamisil® franchises. At Procter and Gamble he helped develop the initial positioning ...
"Oral terbinafine should be prescribed only after topical therapy has failed and for the shortest time possible, in accordance with the current product ...
NM100060 is a topical application of Lamisil ® (terbinafine hydrochloride), formulated with terbinafine and NexMed’s patented NexACT permeation enhancer, ...
The TLT therapy consists of a one-time laser pre-treatment, followed by daily application of a topical terbinafine (the active substance of Lamisil(R)) ...
... was responsible for oversight and management of the dermatology project/product portfolio, including oral and topical Lamisil(R) anti-fungal products. ...
... involve both oral antibiotics and topical ointments. Perhaps the most widely prescribed medicine is terbinafine (marketed as Lamisil or Terbisil); ...
It is a persistent and contagious fungal infection that usually does not respond to topical treatment. «Tinea capitis is a persistent infection that is hard ...
by Staff The US Food and Drug Administration has approved the drug Lamisil in a granular form to treat scalp ringworm in young children. ...
... does not respond to topical treatment, hence the need for a formulation palatable for children. Novartis Pharmaceuticals, who manufacturers Lamisil, ...
It is a persistent and contagious fungal infection that usually does not respond to topical treatment. "Tinea capitis is a persistent infection that is hard ...